Seasonal Influenza Vaccination Resources for Health Professionals
- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 Influenza Season
- TABLE: Influenza vaccines — United States, 2019–20 influenza season
- FIGURE: Influenza vaccine dosing algorithm for children aged 6 months through 8 years — Advisory Committee on Immunization Practices, United States, 2019–20 influenza seasons
- Recommendations regarding influenza vaccination of persons who report allergy to eggs
- CDC Expert Medscape Commentary: 2019-2020 Flu Vaccine Recommendationsexternal icon
- Dosage & Administration (Q&A)
- Large-Scale Influenza Vaccination Clinic Planning
- Vaccine Storage and Handling Guidelines and Recommendations
- Influenza Vaccine Availability Tracking System (IVATS)external icon , a resource to enable healthcare providers to find influenza vaccine to purchase.
- Flu Vaccination & Possible Safety Signal
- Seasonal Influenza Vaccine Effectiveness, 2005-2019
- Flu Vaccine Effectiveness (Q&A for Health Professionals)
- Vaccine Adverse Event Reporting System (VAERS)external icon, also available by telephone at 1–800–822–7967
- Free Resources
- Healthcare Provider Toolkit
- Frequently Asked Flu Questions 2019-2020
- Key Facts about Seasonal Influenza (Q&A)
- Inactivated Flu Vaccine: Vaccination Information Statement (VIS)
- Live, Intranasal Flu Vaccine: Vaccination Information Statement (VIS)
- Make a Strong Flu Vaccine Recommendation
People with a history of egg allergy who have experienced only hives after exposure to egg should receive influenza vaccine. Any licensed, recommended influenza vaccine (i.e., any IIV, RIV4, or LAIV4) that is otherwise appropriate for the recipient’s age and health status may be used.
People who report having had reactions to egg involving symptoms other than hives (e.g., angioedema or swelling, respiratory distress, lightheadedness, or recurrent vomiting) or who required epinephrine or another emergency medical intervention may similarly receive any licensed, recommended influenza vaccine (i.e., any IIV, RIV4, or LAIV4) that is otherwise appropriate for their age and health status. The selected vaccine should be administered in an inpatient or outpatient medical setting (including, but not necessarily limited to, hospitals, clinics, health departments, and physician offices). Vaccine administration should be supervised by a health care provider who is able to recognize and manage severe allergic reactions.
A previous severe allergic reaction to influenza vaccine, regardless of the component suspected of being responsible for the reaction, is a contraindication to future receipt of the vaccine.